|Videos|August 16, 2022
The Importance of Imaging and Centralized Review in Clinical Trials
Author(s)MERIT
Imaging is an integral part of many clinical studies, particularly in the fields of oncology and ophthalmology. Learn why imaging and centralized review are essential for clinical trials, how to address challenges that arise in these studies, and the advantages of partnering with MERIT in this video.
Advertisement
- Imaging provides an unbiased, structural assessment of many disease states, which is a complement to functional outcome measures
- Centralized imaging review is particularly important in Phase II and III trials where multiple imaging sites are involved
- Centralized imaging challenges can be mitigated with 1) imaging expertise, 2) standardization through certified QMS, and 3) an integrated technology platform
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Future for Disease Modifying Therapies for Lysosomal Disorders
2
Accelerating Speed to Patient: A Conversation With Eli Lilly’s Sarah O’Keeffe
3
How New Technologies Are Impacting the Vaccine Market
4
Kardigan Planning for $350 Million IPO Raise: Report
5